Will Healy

Will Healy

Will Healy is a freelance financial writer. He had a lifelong interest in the stock market, trading equities since the dot-com boom. Will pursued his passion for writing after working in the corporate world as both an analyst and an insurance sales professional. He likes to approach the market by focusing on deep value, dividends, and speculation.

Will’s writing has focused on stock analysis, as well as real estate, insurance, personal finance, macroeconomics, and politics. Along with InvestorPlace, his work has appeared on numerous sites, including Seeking Alpha, Yahoo! Finance, MSN Money, Kiplinger Tax Letter, and GOBankingRates. He holds both a B.S. in Journalism and an MBA in finance and strategy.

Recent Articles

Children’s Place Stock Is Still Worth a Look Despite Earnings Stumble

PLCE stock faces tough competition, but with the earnings and revenue beat, financials do not justify the sell-off in Children's Place.

Recent Setbacks Just the Beginning for Netflix Stock

Even though growth remains high for Netflix, NFLX stock has become range bound as it grapples with lower-than-expected revenues and increased competition.

Domination in the Gaming Space Keeps Nvidia Stock Popping

NVDA spiked on news that the new GeForce RTX chips would apply Turing architecture to make ray tracing 25 times faster than before.

Apple Continues to Prosper Even as It Starts to Resemble Its Dow Peers

AAPL stock has moved higher in anticipation of a new iPhone and other products. Finding a better long-term buy will be difficult.

Will Alibaba’s Accounting Issues Be Put to Rest Anytime Soon?

BABA stock continues to enjoy high growth amid trade-related concerns, but doubts about the Alibaba's accounting have not gone away.

Bid to Take Tesla Private Isn’t Recharging TSLA Stock

TSLA stock has struggled - despite the premium on the bid to take the company private as financial issues and Elon Musk's behavior weigh on TSLA stock.

3 Reasons to Sell Roku Stock Despite Its Recent Surge

ROKU stock has performed well recently, but EPS losses, valuation and competitive threats make ROKU stock a sell.

5 Overvalued Tech Stocks Investors Should Consider Selling

Tech stocks have enjoyed an incredible run in recent years, but as a result, some have hit unsustainable valuations. Here are 5 overvalued tech stocks that investors should keep a close eye on.

5 Low-Cost Biotech Stocks With High Levels of Growth

These five biotech stocks balance low valuation with high growth and a track record of profits.

The 5 Best-Performing Stocks of Last Week

Last week's best-performing stocks came from retail, tech and consumer goods. While most climbed on earnings, others climbed on exciting new deals and signs that their plans are working.